Showing results (21-30 of 540) with videos related to
Sort By:
Pageof 54
Comprehensive Physiology|December 29, 2021
Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular RiskPrachi Singh, Naima Covassin, Kara Marlatt, et al.Journal of Nutrition Education and Behavior|October 16, 2018
Relationship Between Perceptions of Obesity Causes and Weight Loss Expectations Among AdultsKatelyn M Daigle, Catherine H Gang, Mariko F Kopping, et al.Journal of the American College of Cardiology|January 6, 2018
Obesity: Pathophysiology and ManagementKishore M Gadde, Corby K Martin, Hans-Rudolf Berthoud, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 9, 2015
Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?Ronette L Kolotkin, Kishore M Gadde, Craig A Peterson, et al.The Journal of Clinical Psychiatry|September 15, 2007
Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label studyKishore M Gadde, Gretchen M Yonish, Mariko S Foust, et al.Diabetes, Obesity & Metabolism|February 17, 2017
Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical studyKishore M Gadde, Marion L Vetter, Nayyar Iqbal, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 14, 2009
Sample size in obesity trials: patient perspective versus current practiceDavid B Allison, Mai A Elobeid, Mark B Cope, et al.International Clinical Psychopharmacology|December 13, 2006
Escitalopram treatment of trichotillomaniaKishore M Gadde, Harry Ryan Wagner, Kathryn M Connor, et al.JAMA|April 10, 2003
Zonisamide for weight loss in obese adults: a randomized controlled trialKishore M Gadde, Deborah M Franciscy, H Ryan Wagner, et al.Journal of Clinical Psychopharmacology|May 1, 2012
Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trialJillon S Vander Wal, Catherine H Gang, George T Griffing, et al.Pageof 54